Absolute quantification of cell-free microRNAs in cancer patients
Manuela Ferracin(University of Ferrara), Massimo Negrini(University of Ferrara), Andrea Rocchi(University of Ferrara), Alan B. Hollingsworth(Mercy Medical Center), Elena Saccenti(University of Ferrara), Maria Vittoria Zanzi(University of Ferrara), Irene Salamon(University of Ferrara), Laura Lupini(University of Ferrara), Paolo Carcoforo(University of Ferrara), Gentian Musa(University of Ferrara), Lucia Da Ros(University of Ferrara), Antonio Frassoldati(University of Ferrara), Barbara Zagatti(University of Ferrara), Giorgio Cavallesco(University of Ferrara), Stefano Volpato(University of Ferrara), Alessandra Mangolini(University of Ferrara), Cristian Bassi(University of Ferrara)
Cited by 125
Related Papers
Zoledronic acid (zoledronate) for postmenopausal women with early breast cancer receiving adjuvant letrozole (ZO-FAST study): final 60-month results
|Annals of Oncology|2012|337
Isolation and characterization of CD146+ multipotent mesenchymal stromal cells
|Experimental Hematology|2008|254
Oncogenic Role of <i>miR-483-3p</i> at the <i>IGF2/483</i> Locus
|Cancer Research|2010|213
Association Between Gait Speed With Mortality, Cardiovascular Disease and Cancer: A Systematic Review and Meta-analysis of Prospective Cohort Studies
|Journal of the American Medical Directors Association|2018|196